AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26280156
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MMF) 0.1% ointment, applied for five consecutive days per week for the entire treatment duration (group B)
Trial: 16021530
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation at 80 mg
Trial: 16021530
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation at 200 mg
Trial: 16021530
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation at 400 mg
Trial: 12548078
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (10 mg/d) for 14 days
Trial: 3847486
Drug: Cefotaxime (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (50 mg/kg/dose every 6 hours)
Trial: 3847486
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (ampicillin and chloramphenicol in standard doses)
Trial: 3847486
Drug: Cefotaxime and
RxNorm normalized name: cefotaxime and beta-lactamase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime and Standard therapy
Trial: 10588216
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (10 mg/day)
Trial: 7979853
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (0.5 mg per single spray)
Trial: 4916870
Drug: Levamisole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (single oral dose)
Trial: 4916870
Drug: Levamisole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (single dose)
Trial: 4916870
Drug: Piperazine citrate
RxNorm normalized name: Piperazine Citrate
DrugBank: Piperazine (DB00592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Piperazine citrate (single dose)
Trial: 23882458
Drug: 0.2% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% chlorhexidine gel
Trial: 17693145
Drug: L-Carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Carnitine (2 g daily for 180 days)
Trial: 12134281
Drug: Pergolide (2.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pergolide (2.25 mg/day)
Trial: 15762
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg thrice daily with meals)
Trial: 15762
Drug: Prindolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prindolol (5 mg thrice daily with meals)
Trial: 15762
Drug: Methyclothiazide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyclothiazide (5 mg with breakfast)
Trial: 15762
Drug: Propranolol doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol doses (120 mg, 60 mg, 40 mg with meals)
Trial: 15762
Drug: Metoprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (200 mg with breakfast, 100 mg with breakfast and evening meal)
Trial: 15762
Drug: Prindolol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prindolol (30 mg, 15 mg, 10 mg with meals)
Trial: 31368283
Drug: Blade needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blade needle therapy (longitudinal cutting along the musculoaponeurotic layer) applied to tender points of the head and neck, treatment conducted once every 3 days for 15 days.
Trial: 31368283
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group receiving Flunarizine Hydrochloride capsules (10 mg) once every night for 15 days.
Trial: 25944513
Drug: Hypocapnia trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocapnia trial (voluntary hyperventilation, minute ventilation = 31 L min(‐1))
Trial: 25944513
Drug: Control trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control trial (spontaneous breathing, minute ventilation = 14 L min(‐1))
Trial: 21971743
Drug: Lying down
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lying down immediately after spinal anesthesia (Group L)
Trial: 19463339
Drug: Intracellular calcium
RxNorm normalized name: ACTIVIN RECEPTOR TYPE IIA (SYNTHETIC HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN HEAVY CHAIN FC FRAGMENT), DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracellular calcium modulator as adjunct to primary PCI
Trial: 2571021
Drug: GHB (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHB (50 mg/kg, orally in a syrup preparation)
Trial: 2571021
Drug: Control syrup
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control syrup (no active treatment)
Trial: 1277749
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin infusion at 12.5 units/min for 1 h
Trial: 1277749
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin infusion at 25 units/min for 1 h
Trial: 1277749
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin infusion (both doses)
Trial: 27978602
Drug: Immediate Implant
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate Implant (IMI)
Trial: 27978602
Drug: Delayed Implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed Implant (DI)
Trial: 23591282
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (BTX) injections (8 × 12.5 U)
Trial: 23591282
Drug: Saline injections
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injections (8 × 0.5 mL)
Trial: 16450086
Drug: Aprepitant (A)
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant (A) regimen: A 125 mg p.o. plus ondansetron (O) 32 mg and dexamethasone (D) 12 mg on day 1; A 80 mg and D 8 mg once daily on days 2-3; and D 8 mg on day 4.
Trial: 16450086
Drug: Control regimen:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control regimen: Ondansetron (O) 32 mg i.v. and dexamethasone (D) 20 mg p.o. on day 1; D 8 mg twice daily on days 2-4.
Trial: 9140160
Drug: Low-dose UDCA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose UDCA (10 mg/kg/day)
Trial: 9140160
Drug: High-dose UDCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose UDCA (20 mg/kg/day)
Trial: 3300423
Drug: Subarachnoid lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subarachnoid lidocaine 1 mg/kg plus salmon calcitonin (sCT) 100 IU
Trial: 28540394
Drug: Two-year oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-year oral health programme
Trial: 26856306
Drug: Simple postal
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple postal intervention highlighting the importance of maintaining asthma medication
Trial: 24499161
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control residence
Trial: 15708844
Drug: 900 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg/day hypericum extract WS 5570 three times a day for six weeks
Trial: 15708844
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg paroxetine once a day for six weeks
Trial: 12408204
Drug: Standard behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard behavioral treatment group including a couples intervention
Trial: 12408204
Drug: Standard behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard behavioral treatment group
Trial: 7657029
Drug: Hyperinsulinemic euglycemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperinsulinemic euglycemic clamp (plasma insulin concentration 586 +/- 9.7 pmol/l) for 13 hours
Trial: 7657029
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion for 13 hours (control)
Trial: 2652546
Drug: CyA and
RxNorm normalized name: CyA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CyA and steroids (Group III)
Trial: 791585
Drug: Indomethacin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (150 mg/day) plus placebo
Trial: 791585
Drug: Indomethacin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (150 mg/day) plus proglumide (900 mg/day)
Trial: 28677982
Drug: Triglyceride (TG)
RxNorm normalized name: CAPRYLIC TRIGLYCERIDE
DrugBank: Tricaprylin (DB12176)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triglyceride (TG) in combination with waist circumference (WC)
Trial: 28677982
Drug: Weekly Cola
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly Cola consumption in women
Trial: 24617605
Drug: Pitavastatin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin (1 mg) with rifampicin (600 mg)
Trial: 24617605
Drug: Rosuvastatin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (5 mg) with rifampicin (600 mg)
Trial: 22733794
Drug: Self-managed computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-managed computer treatment with volunteer support
Trial: 15697102
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel
Trial: 16158750
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (15 mg/day, titrated to a maximum of 45 mg)
Trial: 16158750
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (30 mg and then 45 mg/day for 3 patients)
Trial: 1646290
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg sumatriptan
Trial: 1646290
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg sumatriptan
Trial: 1653137
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatment groups (100 mg, 200 mg, 300 mg sumatriptan)
Trial: 1653137
Drug: Sumatriptan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (all doses)
Trial: 30552060
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of tyrosine with cathodal tDCS
Trial: 18521048
Drug: Black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh (BC) treatment for 12 weeks at a standard dose (Remifemin, 40 mg/day)
Trial: 18521048
Drug: Black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh treatment
Trial: 10519894
Drug: Transplantation (myeloablative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transplantation (myeloablative chemotherapy, total-body irradiation, and transplantation of autologous bone marrow)
Trial: 10519894
Drug: Continuation chemotherapy
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation chemotherapy (intensive chemotherapy alone)
Trial: 31442203
Drug: Achillea wilhelmsii
RxNorm normalized name: Achillea millefolium oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Achillea wilhelmsii C. Koch capsules
Trial: 23739785
Drug: 1.23% APF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.23% APF gel
Trial: 27749616
Drug: Ultrasound-guided steroid
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided steroid injection (40 mg of methylprednisolone)
Trial: 23811617
Drug: Blind steroid
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind steroid injection (40 mg of methylprednisolone)
Trial: 17086095
Drug: Isosorbide-5-mononitrate (IS-5-MN),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (IS-5-MN), 60 mg orally, once daily for 11 months
Trial: 9159453
Drug: Insulin-like growth
RxNorm normalized name: Insulin-like growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-like growth factor binding protein 1 (IGFBP-1)
Trial: 31616139
Drug: Fortasyn Connect
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fortasyn Connect (daily medical food containing docosahexaenoic acid, eicosapentaenoic acid, uridine monophosphate, choline, phospholipids, selenium, folic acid, vitamins B12, B6, C, and E)
Trial: 26112273
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patch (TFP) 12.5 μg/h
Trial: 26112273
Drug: Non-steroid anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroid anti-inflammatory drugs (NSAID)
Trial: 24108510
Drug: Simvastatin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (60 mg)
Trial: 11016522
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment in community mental health centres
Trial: 9686071
Drug: Interscalene brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene brachial plexus block (IBPB) with sedation (midazolam: 1‐3 mg)
Trial: 2943191
Drug: Midazolam 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.07 mg/kg intramuscularly
Trial: 16792771
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of salicylic acid (twice daily then once daily)
Trial: 15119640
Drug: Graduate-measured volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Graduate-measured volume using a 2-L graduated cylinder
Trial: 9517371
Drug: nadolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nadolol (40 mg)
Trial: 7527100
Drug: Trandolapril 0.5
RxNorm normalized name: trandolapril 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 0.5 mg
Trial: 7527105
Drug: Trandolapril 1
RxNorm normalized name: trandolapril 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 1 mg
Trial: 2685740
Drug: Extracorporeal membrane
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal membrane oxygenation (ECMO) therapy
Trial: 29111629
Drug: Muay Thai
RxNorm normalized name: Thai galangal extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muay Thai training twice a week (G2X)
Trial: 20844186
Drug: Increased leucine
RxNorm normalized name: Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased leucine concentration (LEU; 3.5 g leucine)
Trial: 20844186
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CTRL; 1.8 g leucine)
Trial: 29799676
Drug: Rucaparib 40-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rucaparib 40-500 mg QD
Trial: 29799676
Drug: Rucaparib 240-840
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rucaparib 240-840 mg BID
Trial: 29799676
Drug: Rucaparib 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rucaparib 600 mg BID (phase 2)
Trial: 29799676
Drug: Rucaparib 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rucaparib 40 mg (single dose)
Trial: 29799676
Drug: Rucaparib 300
RxNorm normalized name: rucaparib 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rucaparib 300 mg (single dose)
Trial: 25607702
Drug: ALA-PDT (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT (2 treatments)
Trial: 25607702
Drug: ALA-PDT (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT (1 treatment) + ingenol mebutate 0.015% gel (3 days)
Trial: 25607702
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate 0.015% gel alone
Trial: 25607702
Drug: ALA-PDT (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT (1 treatment) + ingenol mebutate gel (3 days)
Trial: 25607702
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate gel alone
Trial: 23826844
Drug: ER tolterodine
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ER tolterodine 4 mg
Trial: 20642044
Drug: Ice gel
RxNorm normalized name: Ice Gel
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice gel
Trial: 18521900
Drug: Selective leukocytapheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective leukocytapheresis (5 sessions, once weekly)
Trial: 18521900
Drug: Unchanged maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unchanged maintenance treatment (Control)
Trial: 12799510
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (conjugate meningococcus C vaccine)
Trial: 11059992
Drug: Risperidone (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (single dose)
Trial: 11059992
Drug: Risperidone (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (six weeks treatment)
Trial: 3745103
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg, sublingual administration)
Trial: 24879495
Drug: THC 29
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 29 mg
Trial: 24879495
Drug: THC 49
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 49 mg
Trial: 24879495
Drug: THC 69
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 69 mg
Trial: 23039319
Drug: High-dose amoxicillin/clavulanic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose amoxicillin/clavulanic acid (80 mg/kg/day for 10 days)
Trial: 23039319
Drug: Cefdinir (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefdinir (14 mg/kg/day for 5 days)
Trial: 15994038
Drug: Tribulus terrestris
RxNorm normalized name: TRIBULUS TERRESTRIS
DrugBank: Tribulus terrestris (DB14358)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribulus terrestris extract (20 mg/kg body weight per day)
Trial: 15994038
Drug: Tribulus terrestris
RxNorm normalized name: TRIBULUS TERRESTRIS
DrugBank: Tribulus terrestris (DB14358)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribulus terrestris extract (10 mg/kg body weight per day)
Trial: 31463821
Drug: Sublingual SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual SAM 10 mg
Trial: 31463821
Drug: Oral SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral SAM 10 mg
Trial: 31463821
Drug: Intravenous SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous SAM
Trial: 31463821
Drug: Oral SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral SAM 10 mg under fed conditions (cohort 1)
Trial: 31463821
Drug: Oral SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral SAM 10 mg for young and elderly participants
Trial: 18562974
Drug: Prescriptions to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescriptions to walk 5-7 days/week
Trial: 18562974
Drug: Prescriptions to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescriptions to walk at moderate intensity
Trial: 14499422
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone (10 mg to 40 mg q12h)
Trial: 11273538
Drug: antacid-acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antacid-acid
Trial: 11273538
Drug: acid-antacid
RxNorm normalized name: calcium carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: acid-antacid
Trial: 11273538
Drug: antacid-antacid (control)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antacid-antacid (control)
Trial: 9089851
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg of nalbuphine intravenously
Trial: 9089851
Drug: 0.0, 0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0, 0.3, 0.6, 0.9, 1.2, and 1.5 mg/kg of 2‐chloroprocaine
Trial: 7693504
Drug: terfenadine, 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine, 180 mg, by mouth
Trial: 7693504
Drug: ipratropium bromide,
RxNorm normalized name: Ipratropium Bromide, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipratropium bromide, 0.5 mg, nebulized